Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASEL | Q05823 | 12/20 | 0.91 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.85 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.85 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.85 |
| ▸ | LDHA | P00338 | 1/20 | 0.85 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.85 |
| ▸ | FBP1 | P09467 | 1/20 | 0.85 |
| ▸ | SRC | P12931 | 1/20 | 0.85 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.85 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.85 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.85 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.85 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.85 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.85 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.85 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.85 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.85 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.85 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.85 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18320406 | 1.00 | RNASEL (0.91) | RNASELDNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL30743061 | 1.00 | RNASEL (0.91) | RNASELDNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL30743062 | 1.00 | RNASEL (0.91) | RNASELDNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL4970108 | 0.96 | RNASEL (0.84) | RNASELDNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL30257834 | 0.95 | RNASEL (0.84) | RNASELDNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL12360933 | 0.95 | RNASEL (1.00) | RNASEL | |
| SCHEMBL29353952 | 0.95 | RNASEL (0.84) | RNASELDNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL12376531 | 0.95 | RNASEL (1.00) | RNASEL | |
| SCHEMBL13513506 | 0.95 | RNASEL (1.00) | RNASEL | |
| SCHEMBL29351236 | 0.95 | RNASEL (1.00) | RNASEL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260005818-A1 | PROTOCOL AND FRAME FORMAT FOR COORDINATED BEAMFORMING | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2026-01-01 | — | — | US | claimed |
| US-12362884-B2 | Protocol and frame format for coordinated beamforming | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2025-07-15 | — | — | US | claimed |
| US-20240356711-A1 | PROTOCOL AND FRAME FORMAT FOR COORDINATED BEAMFORMING | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2024-10-24 | — | — | US | claimed |
| US-12074820-B2 | Protocol and frame format for coordinated beamforming | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2024-08-27 | — | — | US | claimed |
| CN-118335131-A | SOT-MRAM memory cell and controllable logic device | 中电海康集团有限公司 | 2024-07-12 | — | — | CN | claimed |
| EP-4388666-A1 | PROTOCOL AND FRAME FORMAT FOR COORDINATED BEAMFORMING | Huawei Technologies Co., Ltd. (CN) | 2024-06-26 | — | — | EP | claimed |
| CN-117957788-A | Protocol and frame format for coordinated beamforming | 华为技术有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-116110537-B | Diet health management system for salt-sensitive hypertension | 齐齐哈尔医学院 | 2023-09-15 | — | — | CN | claimed |
| CN-116110537-A | Diet health management system for salt-sensitive hypertension | 齐齐哈尔医学院 | 2023-05-12 | — | — | CN | claimed |
| WO-2023046179-A1 | PROTOCOL AND FRAME FORMAT FOR COORDINATED BEAMFORMING | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2023-03-30 | — | — | WO | claimed |
| US-20230102611-A1 | PROTOCOL AND FRAME FORMAT FOR COORDINATED BEAMFORMING | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2023-03-30 | — | — | US | claimed |
| CN-110662886-B | Method for the non-destructive testing of a housing by colorimetry | 赛峰航空器发动机 | 2022-05-13 | — | — | CN | claimed |
| US-12631166-B2 | Fluid routing plug | KERR MACHINE CO. (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026098158-A1 | METHODS AND APPARATUS FOR RESOLVING STATION ID CONFLICT IN COORDINATED BEAMFORMING | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2026-05-15 | — | — | WO | disclosed |
| US-12624684-B2 | Fluid end | KERR MACHINE CO. (US) | 2026-05-12 | — | — | US | disclosed |
| CN-122029860-A | Graph learning subband allocation | 诺基亚技术有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-114080049-A | Channel access method and communication device | 华为技术有限公司 | 2022-02-22 | — | — | CN | disclosed |
| WO-2022033297-A1 | CHANNEL ACCESS METHOD AND COMMUNICATION DEVICE | 华为技术有限公司 | 2022-02-17 | — | — | WO | disclosed |
| WO-2022030213-A1 | WIRELESS COMMUNICATION DEVICE AND WIRELESS COMMUNICATION METHOD | パナソニック インテレクチュアル プロパティ コーポレーション オブ アメリカ | 2022-02-10 | — | — | WO | disclosed |
| CN-114009088-A | Method for enhancing system analysis | 皇家飞利浦有限公司 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12631166-B2 | Fluid routing plug | ABCB11, AQP1, AVPR2 | RNASEL 3347/4885DNPH1 4674/4885PRKAB2 3004/4885 |
| US-12624684-B2 | Fluid end | AQP4, MUC1, SLC26A4 | RNASEL 3599/4885DNPH1 3994/4885PRKAB2 3782/4885 |
| US-20260005818-A1 | PROTOCOL AND FRAME FORMAT FOR COORDINATED BEAMFORMING | SARAF, CACNA1F, CTSF | RNASEL 3263/4885DNPH1 4709/4885PRKAB2 1894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.